Repaglinide
- Product NDC
- 63629-8363
- 11-digit product format
- 636298363
- Labeler code
- 63629
- Product ID
- 63629-8363_da1f638d-f027-4163-8496-17a8fd8ce2e6
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Repaglinide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA203820
- Marketing category
- ANDA
- Marketing start
- 2014-01-22
- Marketing end
- 0000-00-00
- Substance
- REPAGLINIDE
- Active strength
- 2 mg/1
- Pharmacologic classes
- Glinide [EPC], Potassium Channel Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| 668Z8C33LU | REPAGLINIDE | 135062-02-1 | REPAGLINIDE |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 63629-8363-1 | 63629836301 | 30 TABLET in 1 BOTTLE (63629-8363-1) | 30 tablet | 2020-10-19 | 0000-00-00 | No | No | Current |